We are live on ! Find out more
PM

Ponoi Management Portfolio holdings

AUM $73.2M
1-Year Est. Return 23.44%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
-23.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$67.3M
Cap. Flow
-$67.4M
Cap. Flow %
-59.85%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$63.6M
2
NRIX icon
Nurix Therapeutics
NRIX
+$3.85M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPT
1
DELISTED
RAPT Therapeutics
RAPT
$49.7M 44.09%
199,927
– –
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$27.3M 24.24%
1,298,908
– –
RVMD icon
3
Revolution Medicines
RVMD
$47.4B
$18.8M 16.73%
685,011
– –
NRIX icon
4
Nurix Therapeutics
NRIX
$2.79B
$16.8M 14.94%
561,573
-124,701
-18% -$3.85M
CNST
5
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-1,880,623
Closed -$63.6M

Similar funds

RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
SMC
S. Muoio & Co New York $75.7M AUM 42.51% 1-Year Est. Return
CCM
Composite Capital Management Hong Kong $70.1M AUM 79.53% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return

Ponoi Management's Q3 2021 Portfolio in Review

As of Q3 2021, Ponoi Management held 5 positions worth $113M, down 37% from $180M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Ponoi Management withdrew a net $67.4M in Q3 2021, closing 1 position and reducing 1 holding. Its most notable exit was Constellation Pharmaceuticals, Inc., an estimated $63.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi Management's biggest Q3 2021 reduction was Nurix Therapeutics, cutting an estimated $3.85M.
  • Ponoi Management fully exited Constellation Pharmaceuticals, Inc. in Q3 2021, selling an estimated $63.6M.
  • Ponoi Management's ten largest holdings make up 100% of its $113M portfolio in Q3 2021.
  • Ponoi Management opened 0 new positions and closed 1 in Q3 2021.
  • Ponoi Management's portfolio value fell 37% quarter-over-quarter to $113M.

Based on Ponoi Management's 13F filing for Q3 2021, filed 12 Nov 2021.